InvestorsHub Logo
Followers 17
Posts 2081
Boards Moderated 0
Alias Born 04/06/2010

Re: None

Friday, 05/07/2010 1:05:35 AM

Friday, May 07, 2010 1:05:35 AM

Post# of 19507
Found this tonight, not sure if its been posted.

Positron Corporation showcases Attrius PET system at MedAxiom's Spring Conference in Washington D.C., April 16th-18th


Positron Corporation, a molecular imaging solutions company focused on Nuclear Cardiology, will showcase their Attrius PET system at MedAxiom's Spring Conference in Washington D.C., April 16th-18th (www.medaxiom.com). MedAxiom is the largest service provider, information resource and networking organization exclusively for cardiology practices, representing over 5400 physicians and 300 Cardiology practices across the United States.
The MedAxiom Spring Conference targets 5400 physicians covering 45 states with approximately 65% of current attendees being CEO's and other high-level administrators, and the other 35% being cardiologists. "We now have over 250 attendees from over 123 practices from across the United States registered, our highest attendance to date, emphasizing the importance of these kinds of meetings. We're anticipating another great conference," says Chris Romeo, Vice President of Corporate Relations for MedAxiom.

The MedAxiom conferences keep its members informed of changing trends, technologies, strategies and best practices in cardiology-practice administration and service delivery. These meetings allow experts, member practices and industry partners to come together to achieve truly extraordinary results for practice optimization. The conferences consist of both large-group presentations including all members and breakout sessions for small-group discussions on more specific issues.

Positron will sponsor a Partner Spotlight Luncheon, Saturday, April 17th, titled: Cardiac PET -- The Present and Future of Perfusion Imaging.

Joseph Oliverio, Chief Technology Officer of Positron states, "Cardiac PET is emerging as the preferred nuclear cardiology imaging modality and Positron looks forward to educating the MedAxiom attendees of the benefits of adding Positron's Attrius PET to their practice." Mr. Oliverio further states, "The MedAxiom conference will demonstrate the market shift from SPECT to PET. Positron looks to deliver its Attrius and PET solutions to MedAxiom's cardiology practices as their membership represents the leaders in the cardiology. Positron has the only dedicated PET system in the marketplace and expects to meet the unprecedented market demand with significant sales as a result of our corporate sponsorship."